Ketobemidone

Ketobemidone

File:Ketobemidon.svg
Clinical data
Synonyms	Ketobemidone, Cliradon, Cymidon, Ketogan, Ketorax
Routes of administration	Oral, rectal, intravenous
Legal status
Legal status	US: Schedule I
Pharmacokinetic data
Bioavailability	34% (oral), 44% (rectal)
Identifiers
IUPAC name 1-[4-(3-hydroxyphenyl)-1-methyl-4-piperidyl]propan-1-one
CAS Number	469-79-4
PubChem CID	10101
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C15H21NO2
Molar mass	247.333 g/mol

WikiDoc Resources for Ketobemidone
Articles
Most recent articles on Ketobemidone Most cited articles on Ketobemidone Review articles on Ketobemidone Articles on Ketobemidone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ketobemidone Images of Ketobemidone Photos of Ketobemidone Podcasts & MP3s on Ketobemidone Videos on Ketobemidone
Evidence Based Medicine
Cochrane Collaboration on Ketobemidone Bandolier on Ketobemidone TRIP on Ketobemidone
Clinical Trials
Ongoing Trials on Ketobemidone at Clinical Trials.gov Trial results on Ketobemidone Clinical Trials on Ketobemidone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ketobemidone NICE Guidance on Ketobemidone NHS PRODIGY Guidance FDA on Ketobemidone CDC on Ketobemidone
Books
Books on Ketobemidone
News
Ketobemidone in the news Be alerted to news on Ketobemidone News trends on Ketobemidone
Commentary
Blogs on Ketobemidone
Definitions
Definitions of Ketobemidone
Patient Resources / Community
Patient resources on Ketobemidone Discussion groups on Ketobemidone Patient Handouts on Ketobemidone Directions to Hospitals Treating Ketobemidone Risk calculators and risk factors for Ketobemidone
Healthcare Provider Resources
Symptoms of Ketobemidone Causes & Risk Factors for Ketobemidone Diagnostic studies for Ketobemidone Treatment of Ketobemidone
Continuing Medical Education (CME)
CME Programs on Ketobemidone
International
Ketobemidone en Espanol Ketobemidone en Francais
Business
Ketobemidone in the Marketplace Patents on Ketobemidone
Experimental / Informatics
List of terms related to Ketobemidone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Ketobemidone is a powerful opioid analgesic. Its potency is equal to morphine, and it also has some NMDA-antagonist properties. This makes it useful for some types of pain that don't respond well to other opioids.

It is used for all types of severe pain, such as postoperative, cancer, kidney stones and fractures.

History

It was first synthesized in 1942 by Eisleb. The first study of it in man was published in 1946, and it was introduced in clinical medicine shortly after.

Chemistry

Ketobemidone is 1-methyl-4-(3-hydroxyphenyl)-4-propionylpiperidine. It is usually available as the hydrochloride, which is a white powder. It is synthesized by alkylating (3-methoxyphenyl)acetonitrile with bis(2-chloroethyl)methylamine, followed by reaction with ethylmagnesiumbromide, and finally O-demethylation with hydrobromic acid.

Pharmacology

Experiments on former addicts indicated it was more addictive than other opioids, so in 1954 the Economic and Social Council took a resolution urging governments to stop manufacture and use of ketobemidone . As a result ketobemidone is mostly used in the Scandinavian countries, with Denmark topping the statistics . This result was not in agreement with clinical observations, and another study in 1958 didn't find it more addictive than morphine. That study noticed that while for morphine the dose for euphoria is the same as that for analgesia, for ketobemidone the analgesic dose was well below the euphoric dose.

Analgesia after 5-10 mg orally or 5-7.5 mg intravenously lasts 3-5 hours. Ketobemidone is also available in preparations with a spasmolytic, which can improve the analgesia.

Ketobemidone is mainly metabolised by conjugation of the phenolic hydroxyl group, and by N-desmethylation. Only about 16% is excreted unchanged.

Pfizer manufactures ketobemidone under the tradenames Ketogan and Ketorax. It is available as tablets, suppositories and injection fluid. A sustained release formulation exists sold as Ketodur in some countries containing 10 or 25 mg ketobemidone.